GlassScriptPhysician profile
Venu Divi
NPI 1245390228
$3,183.75
in general payments reported to CMS, 2019-2025
19 companies · $815 in 2025
The $815 reported for 2025 was more than what 75% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $263 · 2020: $215 · 2021: $421 · 2022: $591 · 2023: $459 · 2024: $419 · 2025: $815.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,659 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,658.91 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $613.50 | 2019-2025 | |
| Acclarent, INC | $594.41 | 2019-2024 | Acclarent Aera, Trudi Nav Cable |
| Glaxosmithkline, LLC. | $537.45 | 2021-2025 | Nucala |
| Stryker Corporation | $317.66 | 2019-2025 | Xpress Loprofile |
| Genzyme Corporation | $256.70 | 2021-2025 | |
| Integra Lifesciences Corporation | $204.72 | 2024-2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Aerin Medical INC. | $134.31 | 2020-2024 | |
| Baxter Healthcare | $125.00 | 2025 | Perclot |
| Regeneron Healthcare Solutions, INC. | $99.70 | 2021-2024 | Dupixent |
| Inspire Medical Systems, INC. | $44.60 | 2024 | Inspire |
| Hikma Pharmaceuticals USA | $43.39 | 2024-2025 | Ryaltris |
| Olympus America INC. | $42.87 | 2021 | |
| Amgen INC. | $34.00 | 2025 | |
| Medtronic, INC. | $32.92 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $32.63 | 2025 | Tezspire |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $24.16 | 2023 | |
| Tactile Systems Technology INC | $17.11 | 2022 | |
| Karl Storz Endoscopy-America | $15.50 | 2020 | |
| Intersect Ent, INC. | $13.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Venu Divi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.